IRIS UniCatt

Siciliano, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.463
EU - Europa 2.328
AS - Asia 1.772
SA - Sud America 338
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 3
Totale 6.944
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.411
DE - Germania 989
SG - Singapore 937
CN - Cina 447
SE - Svezia 416
BR - Brasile 297
UA - Ucraina 207
IT - Italia 180
FR - Francia 116
GB - Regno Unito 102
IE - Irlanda 102
FI - Finlandia 79
VN - Vietnam 74
ID - Indonesia 62
IN - India 58
TR - Turchia 47
RU - Federazione Russa 42
HK - Hong Kong 30
CA - Canada 29
BE - Belgio 22
IR - Iran 21
AR - Argentina 18
BD - Bangladesh 18
IQ - Iraq 17
MX - Messico 16
PL - Polonia 16
CI - Costa d'Avorio 13
JP - Giappone 12
AT - Austria 9
EU - Europa 8
NL - Olanda 8
AE - Emirati Arabi Uniti 7
ZA - Sudafrica 7
EC - Ecuador 6
LT - Lituania 6
PK - Pakistan 6
AZ - Azerbaigian 5
GR - Grecia 5
SA - Arabia Saudita 5
CH - Svizzera 4
DK - Danimarca 4
JO - Giordania 4
VE - Venezuela 4
AU - Australia 3
CL - Cile 3
CZ - Repubblica Ceca 3
ES - Italia 3
IL - Israele 3
KG - Kirghizistan 3
PE - Perù 3
PT - Portogallo 3
RO - Romania 3
UZ - Uzbekistan 3
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
KE - Kenya 2
KR - Corea 2
MA - Marocco 2
MK - Macedonia 2
PY - Paraguay 2
AD - Andorra 1
BG - Bulgaria 1
BH - Bahrain 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
MN - Mongolia 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.944
Salva come PNG Salva come JPEG
Città #
Singapore 513
Chandler 469
Ashburn 201
Jacksonville 121
Beijing 106
San Mateo 104
Dublin 101
Dallas 85
Ann Arbor 74
New York 71
Nürnberg 62
Jakarta 59
Wilmington 58
Cattolica 57
Nanjing 57
Boston 48
Munich 47
Dearborn 46
Los Angeles 46
The Dalles 42
Woodbridge 39
Izmir 38
Marseille 32
Princeton 32
Helsinki 31
Ho Chi Minh City 31
Redwood City 31
Bremen 26
Houston 26
Moscow 26
Nanchang 26
Zhengzhou 25
Hong Kong 23
Lawrence 23
Brussels 22
Frankfurt am Main 22
São Paulo 21
Augusta 20
Hefei 20
Rome 20
Hangzhou 19
Lancaster 19
Leawood 19
Tianjin 19
Andover 18
Hebei 17
Seattle 16
Buffalo 15
Shenyang 15
Boardman 14
Santa Clara 14
Abidjan 13
Fairfield 13
Hanoi 13
Warsaw 13
Changsha 12
Falls Church 12
Phoenix 12
Turku 12
Kunming 11
Milan 11
Shanghai 11
Stockholm 11
Atlanta 10
London 10
Norwalk 10
Tokyo 10
University Park 10
Toronto 9
Guangzhou 8
Kish 8
Rio de Janeiro 8
Salvador 8
Bologna 7
Curitiba 7
Jiaxing 7
Las Vegas 7
Mountain View 7
Nuremberg 7
Amsterdam 6
Baghdad 6
Brooklyn 6
Detroit 6
Goiânia 6
Jinan 6
Kent 6
Mcallen 6
Ardabil 5
Belo Horizonte 5
Cambridge 5
Chicago 5
Dhaka 5
Düsseldorf 5
Falkenstein 5
Johannesburg 5
Mexico City 5
Montreal 5
Paris 5
Poplar 5
San Diego 5
Totale 3.476
Salva come PNG Salva come JPEG
Nome #
Etanercept therapy in two patients with psoriasis and concomitant hepatitis C 240
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 221
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 190
A pilot study of capsule endoscopy after a standard meal for the detection and grading of oesophageal varices in cirrhotic patients 185
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 176
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 166
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 164
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 163
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 156
Liver transplantation in patients with alcoholic liver disease: A retrospective study 154
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 153
A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy 150
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 148
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data. 147
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 147
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 141
Microscopic colitis 138
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 135
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 135
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 132
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 129
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 128
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 128
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 127
Model for end-stage liver disease dynamic stratification of survival benefit 127
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 123
Donor risk index and organ patient index as predictors of graft survival after liver transplantation 120
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 117
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 117
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 112
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 111
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 110
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 110
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 108
ANGIOTENSIN-CONVERTING ENZYME I/D POLYMORPHISM IS ASSOCIATED WITH SIGNIFICANTLY DIFFERENT VALUES OF HEPATIC VENOUS PRESSURE GRADIENT IN PATIENTS WITH LIVER CIRRHOSIS 107
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation 106
ACE I allele is associated with more severe portal hypertension in patients with liver cirrhosis: A pilot study 106
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 106
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports 106
Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project 106
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 101
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 99
Regorafenib: a promising treatment for hepatocellular carcinoma 98
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 95
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 94
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 92
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 91
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 90
Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation 90
[Chronic hepatitis C virus infection: clinical picture and treatment possibilities] 86
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C 82
The new era of hepatitis C treatment: still the tip of the iceberg? 74
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 68
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 66
Donor-Recipient MELD-Based Match in a Patient Who Required Three Liver Grafts in the Era of Nonstandard Donors: Case Report 65
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 64
Late Development of Splenic Artery Aneurysm After Orthotopic Liver Transplantation: A Case Report 61
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 54
Totale 7.015
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.720
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021294 0 0 0 0 0 29 48 11 58 33 99 16
2021/2022598 37 55 15 39 42 18 10 120 28 38 80 116
2022/20231.201 150 160 118 202 61 171 54 95 128 7 37 18
2023/2024470 24 150 21 32 12 83 24 6 5 21 43 49
2024/2025964 16 34 84 23 111 28 25 48 149 99 196 151
2025/20261.541 397 51 178 275 601 39 0 0 0 0 0 0
Totale 7.015